Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ERX-315 |
Synonyms | |
Therapy Description |
ERX-315 is a synthesized oligobenzamide that induces ER stress, potentially leading to decreased tumor cell proliferation and inhibition of tumor growth (Cancer Res (2024) 84 (9_Supplement): PO3-26-11). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ERX-315 | ERX 315|ERX315 | ERX-315 is a synthesized oligobenzamide that induces ER stress, potentially leading to decreased tumor cell proliferation and inhibition of tumor growth (Cancer Res (2024) 84 (9_Supplement): PO3-26-11). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06533332 | Phase I | ERX-315 | A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors | Recruiting | AUS | 0 |